Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pleural Effusion × Deoxyribonucleases × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pulmonary Embolism 1 Pneumothorax 1 Pleural Effusion 1 Pleural Diseases 1 Lung Neoplasms 1

Interventions

Thoracoscopy 2 vandetanib 1 dalotuzumab 1 X-Rays 1 Ultrasonography 1 Tyrosine Kinase Inhibitors 1 Tissue Plasminogen Activator 1 Tenecteplase 1 Saline Solution 1 Povidone-Iodine 1 Pleurodesis 1 Octreotide 1 Naproxen 1 Gemcitabine 1 Fentanyl 1 Diclofenac 1 Deoxyribonucleases 1 Dasatinib 1 Clinical Laboratory Techniques 1 Cisplatin 1 Chest Tubes 1 Afatinib 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03167281 2025-02-21

ELEVATE

Prisma Health-Midlands

Phase 4 Withdrawn

Lung Neoplasms, Pleural Diseases, Pleural Effusion, Pneumothorax, Pulmonary Embolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡